Instruction for use: Albarel

Dosage form: tablets

Active substance: Rilmenidinum

ATX

C02AC06 Rilmenidine

Pharmacological group

Hypotensive central agent [I1-imidazoline receptor agonists]

Nosological classification (ICD-10)

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

Composition

Tablets - 1 table.

active substance: Rilmenidine dihydrogen phosphate 1.544 mg

(Corresponds to the content of rilmenidine - 1 mg)

Auxiliary substances: sodium carboxymethyl starch - 4.5 mg; MCC - 33.646 mg; Lactose - 47 mg; Paraffin, solid - 0.155 mg; Silicon dioxide colloidal anhydrous - 0.23 mg; Magnesium stearate - 0.9 mg; Talcum - 2 mg; Wax bee white - 0.025 mg

Pharmachologic effect

Mode of action - hypotensive.

Dosing and Administration

Inside, at the beginning of food intake, 1 table. The day in the morning.

In the absence of a therapeutic effect, the dose of the drug can be increased to 2 tablets. A day (1 table in the morning, 1 table in the evening during a meal). The maximum daily dose is 2 mg.

With renal insufficiency with Cl creatinine above 15 ml / min, dose adjustment is not required.

Release form

Tablets, 1 mg. For 10 tab. In a blister of PA / aluminum foil / PVC // aluminum foil. 1, 2 or 3 blisters in a cardboard bundle.

Manufacturer

CJSC "Pharmaceutical Plant EGIS". 1106, Budapest, st. Keresturi, 30-38, Hungary.

Manufacturer of ready-made dosage form / licensor: Laboratories Servier - France

Conditions of supply of pharmacies

On prescription.

Storage conditions of the drug Albarel

At temperatures below 30 ° C.

Keep out of the reach of children.

The shelf life of the drug Albarel

2 years.

Do not use beyond the expiration date printed on the package.